InsiderTrades.com logo

MTCR Insider Trading

Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 13.80%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Metacrine Insider Trading History Chart

This chart shows the insider buying and selling history at Metacrine by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Metacrine Share Price & Price History

Current Price: $0.58
Price Change: +0.30 (1.20%)
As of 06/20/2023 01:00 AM ET

This chart shows the closing price history over time for MTCR up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Metacrine Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/26/2023Michael YorkInsiderSell107,054$0.41$43,892.14103,499View SEC Filing Icon  
1/26/2023Preston KlassenCEOSell380,605$0.41$156,048.05541,905View SEC Filing Icon  
12/21/2022Braden Michael LeonardMajor ShareholderBuy120,099$0.40$48,039.606,160,570View SEC Filing Icon  
12/19/2022Braden Michael LeonardMajor ShareholderBuy101,384$0.40$40,553.605,990,349View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Metacrine (NASDAQ:MTCR)

37.72% of Metacrine stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at MTCR by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Metacrine Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/15/2023Tang Capital Management LLC4,250,000$1.90M0.3%+147.3%9.984%Search for SEC Filing on Google Icon
2/13/2023BML Capital Management LLC6,167,458$2.76M2.6%N/A14.488%Search for SEC Filing on Google Icon
11/15/2022Tang Capital Management LLC1,718,220$0.83M0.1%N/A4.036%Search for SEC Filing on Google Icon
11/14/2022Tudor Investment Corp Et Al349,100$0.17M0.0%N/A0.820%Search for SEC Filing on Google Icon
5/27/2022ARCH Venture Management LLC2,940,503$1.79M0.3%N/A6.924%Search for SEC Filing on Google Icon
2/10/2022Acadian Asset Management LLC84,442$56K0.0%N/A0.309%Search for SEC Filing on Google Icon
2/2/2022Cim Investment Management Inc.38,108$78K0.0%+100.0%0.139%Search for SEC Filing on Google Icon
11/17/2021ArrowMark Colorado Holdings LLC281,467$0.97M0.0%-73.1%1.030%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Advisers LP136,400$0.47M0.0%+176.1%0.514%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Investments LP123,659$0.42M0.0%+90.8%0.466%Search for SEC Filing on Google Icon
11/15/2021Franklin Resources Inc.363,600$1.25M0.0%-72.2%1.371%Search for SEC Filing on Google Icon
11/12/2021Renaissance Technologies LLC283,100$0.97M0.0%+254.3%1.067%Search for SEC Filing on Google Icon
11/12/2021Prosight Management LP1,145,034$3.93M2.2%+31.8%4.317%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.137,919$0.47M0.0%+19.8%0.520%Search for SEC Filing on Google Icon
9/3/2021Parametric Portfolio Associates LLC55,753$0.21M0.0%-40.8%0.210%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC261,420$0.99M0.0%-8.9%0.989%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp12,231$46K0.0%-83.0%0.046%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Metacrine logo
Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with gastrointestinal diseases. It is developing MET642, which has completed Phase I clinical trial for the treatment of ulcerative colitis. Metacrine, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Read More on Metacrine

Today's Range

Now: $0.58
Low: $0.58
High: $0.59

50 Day Range

MA: $0.57
Low: $0.55
High: $0.59

52 Week Range

Now: $0.58
Low: $0.30
High: $0.59

Volume

83,889 shs

Average Volume

225,834 shs

Market Capitalization

$24.75 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A